Description:

Plaquenil maculopathy is a rare, but visually debilitating complication of using hydroxychloroquine medication. This course details utilizing special testing including Visual Fields and OCT for diagnosis. The 2011 and 2016 American Academy of Ophthalmology management recommendations including treatment and follow-up will be discussed, including what height, weight, and dosage constitutes high risk. New information about risk modification will help the optometrist manage patients on Plaquenil.

Course Code:

AOA259-PH

Speaker(s):

Anthony DeWilde, O.D.
anthony.dewilde@va.gov

Credits:

1

AOA Expiration Date:

3/4/2025

Related News

Partners in care

A successful practice takes a village—doctors of optometry and paraoptometric staff—to make it work and even prosper. Toward that end, the AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.

4 tips for handling payer clawbacks: What the experts say

A recent #AskAOA webinar, hosted by the AOA Third Party Center, offered helpful advice for how doctors can address and respond to clawbacks.

Webinar takes on sensitive topic of human trafficking

Most states require health care providers, including doctors of optometry, to report cases of abuse of children and elderly adults. AOA members are invited to attend an important webinar on the serious subject of human trafficking.